Virginie Sophie Poncelet,Sophie Coupa,Pierre-Henri Storck,Bruno Schoentjes
申请号：
US15398291
公开号：
US20170112818A1
申请日:
2017.01.04
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides compounds of formula (I), their use as an inhibitor of a p53-MDM2 interaction as well as pharmaceutical compositions comprising said compounds:wherein n, m, p, s, t, R1, R2, R3, R4, R5, R6, R7, R20, X, Y, Q and Z have defined meanings.
